STAGING OF PANCREATIC NEUROENDOCRINE TUMOR (LITERATURE REVIEW)
https://doi.org/10.16931/1995-5464.2017370-76
Abstract
Survival of patients with pancreatic neuroendocrine tumor is determined by many factors. An important role is played by accurate selection of patients for different treatment modalities, that is clearly determined by adequate cancer staging. To date there are two TNM-classifications of pancreatic neuroendocrine tumors which are differ greatly among themselves - European Neuroendocrine Tumor Society TNM-staging system (2006) and American Joint Cancer Committee TNM staging system (2010). We have reviewed the most significant publications related to the analysis of TNM systems accuracy for these tumors. These data suggest that European Neuroendocrine Tumor Society TNM-staging system is superior to the American Joint Cancer Committee TNM-staging system. Considering the low incidence of pancreatic neuroendocrine tumors only further large multi-center studies will improve the staging of these tumors.
About the Authors
A. V. Glotov
A.V. Vishnevsky Institute of Surgery of the Russian Ministry of Healthcare.
Russian Federation
Russian Federation
Glotov Andrey Vyacheslavovich – Junior Researcher of the Pathology Department of A.V. Vishnevsky Institute of Surgery of the Russian Ministry of Healthcare.
For correspondence: Proizvodstvennaja str. 1-2-4, Moscow, 119619, Russian Federation. Phone: +7-906-776-21-77. E-mail: andrew.glotov@mail.ru
D. V. Kalinin
A.V. Vishnevsky Institute of Surgery of the Russian Ministry of Healthcare.
Russian Federation
Kalinin Dmitriy Valer'yevich – Cand. of Med. Sci., Head of the Pathology Department of A.V. Vishnevsky Institute of Surgery of the Russian Ministry of Healthcare.
Russian Federation
Kalinin Dmitriy Valer'yevich – Cand. of Med. Sci., Head of the Pathology Department of A.V. Vishnevsky Institute of Surgery of the Russian Ministry of Healthcare.
A. V. Smirnov
A.V. Vishnevsky Institute of Surgery of the Russian Ministry of Healthcare.
Russian Federation
Smirnov Aleksandr Vyacheslavovich – Postgraduate Student of the Abdominal Surgery Department of A.V. Vishnevsky Institute of Surgery of the Russian Ministry of Healthcare.
Russian Federation
Smirnov Aleksandr Vyacheslavovich – Postgraduate Student of the Abdominal Surgery Department of A.V. Vishnevsky Institute of Surgery of the Russian Ministry of Healthcare.
A. G. Kriger
A.V. Vishnevsky Institute of Surgery of the Russian Ministry of Healthcare.
Russian Federation
Kriger Andrey Germanovich – Doct. of Med. Sci., Professor, Head of the Abdominal Surgery Department №1 of A.V. Vishnevsky Institute of Surgery of the Russian Ministry of Healthcare.
Russian Federation
Kriger Andrey Germanovich – Doct. of Med. Sci., Professor, Head of the Abdominal Surgery Department №1 of A.V. Vishnevsky Institute of Surgery of the Russian Ministry of Healthcare.
References
1. Bosman F. WHO Classification of tumours of the digestive system. Lyon: IARC Press, 2010. 417 p.
2. Modlin I.M., Oberg K., Chung D.C., Jensen R.T., de Herder W.W., Thakker R.V., Caplin M., DelleFave G., Kaltsas G.A., Krenning E.P., Moss S.F., Nilsson O., Rindi G., Salazar R., Ruszniewski P., Sundin A. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008; 9 (1): 61–72. DOI: 10.1016/S1470-2045(07)70410-2.
3. DeLellis R. Pathology and genetics of tumours of endocrine organs. Lyon: IARC Press, 2004. 320 p.
4. Aaltonen L., Hamilton S. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press, 2000. 314 p.
5. Klimstra D.S., Modlin I.R., Adsay N.V., Chetty R., Deshpande V., Gönen M., Jensen R.T., Kidd M., Kulke M.H., Lloyd R.V., Moran C., Moss S.F., Oberg K., O'Toole D., Rindi G., Robert M.E., Suster S., Tang L.H., Tzen C.Y., Washington M.K., Wiedenmann B., Yao J. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set. Am. J. Surg. Pathol. 2010; 34 (3): 300–313. DOI: 10.1097/PAS.0b013e3181ce1447.
6. Niederle M., Hackl M., Kaserer K., Niederle B. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters. Endocr. Relat. Cancer. 2010; 17 (4): 909–918. DOI: 10.1677/ERC-10-0152.
7. Ferrone C.R., Tang L.H., Tomlinson J., Gonen M., Hochwald S.N., Brennan M.F., Klimstra D.S., Allen P.J. Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO Classification system be simplified? J. Clin. Oncol. 2007; 25 (35): 5609–5615.
8. Hruban R., Bishop Pitman M., Klimstra D. Tumors of the pancreas. Washington: ARP, AFIP, 2007. 417 p.
9. Rindi G., Klöppel G., Alhman H., Caplin M., Couvelard A., de Herder W.W., Erikssson B., Falchetti A., Falconi M., Komminoth P., Körner M., Lopes J.M., McNicol A.M., Nilsson O., Perren A., Scarpa A., Scoazec J.Y., Wiedenmann B. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006; 449 (4): 395–401. DOI: 10.1007/s00428-006-0250-1.
10. Sobin L., Gospodarowicz M., Wittekind C. TNM Classification of malignant tumours. 7th ed. West Sussex, UK: Chichester; NJ: Wiley-Blackwell, 2009. 310 p.
11. Edge S., Byrd D.R., Compton C.C., Fritz A.G., Greene F.L., Trotti A. AJCC Cancer Staging Manual. New York: Springer, 2010. 648 p.
12. Fischer L., Kleeff J., Esposito I., Hinz U., Zimmermann A., Friess H., Büchler M.W. Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. Br. J. Surg. 2008; 95 (5): 627–635. DOI: 10.1002/bjs.6051.
13. Ekeblad S., Skogseid B., Dunder K., Oberg K., Eriksson B. Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Clin. Cancer Res. 2008; 14 (23): 7798–7803. DOI: 10.1158/1078-0432.CCR-08-0734.
14. Pape U.F., Jann H., Müller-Nordhorn J., Bockelbrink A., Berndt U., Willich S.N., Koch M., Röcken C., Rindi G., Wiedenmann B. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer. 2008; 113 (2): 256–265. DOI: 10.1002/cncr.23549.
15. La Rosa S., Klersy C., Uccella S., Dainese L., Albarello L., Sonzogni A., Doglioni C., Capella C., Solcia E. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. Hum. Pathol. 2009; 40 (1): 30–40. DOI: 10.1016/j.humpath.2008.06.005.
16. Strosberg J.R., Cheema A., Weber J., Han G., Coppola D., Kvols L.K. Prognostic validity of a novel american joint committee on cancer staging classification for pancreatic neuroendocrine tumors. J. Clin. Oncol. 2011; 29 (22): 3044–3049. DOI: 10.1200/JCO.2011.35.1817.
17. Yang M., Zeng L., Zhang Y., Wang W.G., Wang L., Ke N.W., Liu X.B., Tian B.L. TNM staging of pancreatic neuroendocrine tumors. Medicine (Baltimore). 2015; 94 (12): e660. DOI: 10.1097/MD.0000000000000660.
18. Rindi G., Falconi M., Klersy C., Albarello L., Boninsegna L., Buchler M.W., Capella C., Caplin M., Couvelard A., Doglioni C., DelleFave G., Fischer L., Fusai G., de Herder W.W., Jann H., Komminoth P., de Krijger R.R., La Rosa S., Luong T.V., Pape U., Perren A., Ruszniewski P., Scarpa A., Schmitt A., Solcia E., Wiedenmann B. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J. Natl. Cancer Inst. 2012; 104 (10): 764–777. DOI: 10.1093/jnci/djs208.
19. Scarpa A., Mantovani W., Capelli P., Beghelli S., Boninsegna L., Bettini R., Panzuto F., Pederzoli P., delleFave G., Falconi M. Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients. Mod. Pathol. 2010; 23 (6): 824–833. DOI: 10.1038/modpathol.2010.58.
Review
For citations:
Glotov A.V., Kalinin D.V., Smirnov A.V., Kriger A.G. STAGING OF PANCREATIC NEUROENDOCRINE TUMOR (LITERATURE REVIEW). Annaly khirurgicheskoy gepatologii = Annals of HPB Surgery. 2017;22(3):70-76. (In Russ.) https://doi.org/10.16931/1995-5464.2017370-76
Views:
932
Email this article 